SENSEI BIOTHERAPEUTICS INC

Historical 13F Holders

Symbol: FTH
CUSIP: 81728A207
All holders as of: Q2 2026
Type: Equity
Class: COM NEW

Reported Value, Excluding Options

Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 81728A207 since 12/18/2024, newest first.

Filer	% of Class	Shares	Form	Filed
Caligan Partners LP 13G/A Amendment 1	2.4%	629,467	13G/A Amendment 1	8/14/2026 Event 6/30/2026
Caligan Partners LP	2.4%	629,467
David Johnson	2.4%	629,467
Trails Edge Capital Partners, LP 13G/A Amendment 1	2.0%	515,335	13G/A Amendment 1	8/14/2026 Event 6/30/2026
Trails Edge Capital Partners, LP	2.0%	515,335
Trails Edge Biotechnology Master Fund, LP	2.0%	515,335
Ortav Yehudai	2.0%	515,335
Khosla Ventures VI, L.P. 13G	10.2%	2,632,232	13G	8/14/2026 Event 6/15/2026
Khosla Ventures VI, LP	6.4%	1,643,349
Khosla Ventures Seed D, LP	3.8%	988,883
Khosla Ventures Associates VI, LLC	6.4%	1,643,349
Khosla Ventures Seed Associates D, LLC	3.8%	988,883
VK Services, LLC	10.2%	2,632,232
Vinod Khosla	10.2%	2,632,232
StemPoint Capital LP 13G/A Amendment 1	0%	0	13G/A Amendment 1	8/14/2026 Event 6/30/2026
StemPoint Capital LP	0%	0
StemPoint Capital Management GP LLC	0%	0
Michelle Ross	0%	0
S2G Investments, LLC 13G	10.0%	2,575,401	13G	6/23/2026 Event 6/15/2026
Suvretta Capital Management, LLC 13G	7.8%	2,020,103	13G	6/23/2026 Event 6/15/2026
Suvretta Capital Management, LLC	7.8%	2,020,103
Averill Master Fund, Ltd.	6.7%	1,722,652
Aaron Cowen	7.8%	2,020,103
Millennium Management LLC 13G/A Amendment 1	3.1%	41,561	13G/A Amendment 1	6/3/2026 Event 6/1/2026
ICS Opportunities II LLC	3.1%	41,561
Millennium Management LLC	3.1%	41,561
Millennium Group Management LLC	3.1%	41,561
Israel A. Englander	3.1%	41,561
Millennium Management LLC 13G	9.6%	128,761	13G	5/15/2026 Event 2/24/2026
ICS Opportunities II LLC	9.5%	127,917
Millennium Management LLC	9.6%	128,761
Millennium Group Management LLC	9.6%	128,761
Israel A. Englander	9.6%	128,761
StemPoint Capital LP 13G	9.9%	132,873	13G	5/15/2026 Event 3/31/2026
StemPoint Capital LP	9.9%	132,873
StemPoint Capital Management GP LLC	9.9%	132,873
Michelle Ross	9.9%	132,873
Caligan Partners LP 13G	9.4%	126,002	13G	5/15/2026 Event 3/31/2026
Caligan Partners LP	9.4%	126,002
David Johnson	9.4%	126,002
Trails Edge Capital Partners, LP 13G	9.9%	126,010	13G	2/25/2026 Event 2/18/2026
Trails Edge Capital Partners, LP	9.9%	126,010
Trails Edge Biotechnology Master Fund, LP	9.9%	126,010
Ortav Yehudai	9.9%	126,010

13F Holders by Quarter

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q2	45	14.1 M	$334 M	$0
2026 Q1	31	2.29 M	$72.2 M	$0
2025 Q4	10	48.2 k	$515 k	$0
2025 Q3	10	49.4 k	$467 k	$0
2025 Q2	11	69.9 k	$600 k	$0
2025 Q1	1	16.5 k	$6.51 k	$0